ursodeoxycholic acid has been researched along with Lupus Nephritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, T; Kadokawa, Y; Kohno, S; Matsuo, I; Miyazaki, M; Nishino, T; Ohba, K; Omagari, K; Otsu, Y; Taguchi, T; Yamamoto, U | 1 |
Lagoo, A; McMurray, RW; Suwannaroj, S | 1 |
2 other study(ies) available for ursodeoxycholic acid and Lupus Nephritis
Article | Year |
---|---|
Primary sclerosing cholangitis associated with lupus nephritis: a rare association.
Topics: Biopsy, Needle; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Japan; Lupus Nephritis; Middle Aged; Prednisolone; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2003 |
Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Topics: Albuminuria; Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cytokines; Disease Models, Animal; Female; Gastrointestinal Agents; Hemocyanins; Immunization; Immunoglobulin G; Kidney; Liver; Lupus Nephritis; Mice; Mice, Inbred NZB; Spleen; Survival Rate; Uremia; Urodynamics; Ursodeoxycholic Acid | 2001 |